“…MHC-I molecules are again monitored for high-affinity peptide occupancy by a system that is related to the standard glycoprotein quality control (Ellgaard and Helenius, 2001). It recognizes suboptimally loaded MHC-I, most likely through UDP-glucose:glycoprotein glucosyltransferase (UGT1), retains them in the ER-Golgi intermediate compartment (ERGIC) and the cis-Golgi, prevents them from becoming endoglycosidase H resistant, and eventually returns them to the ER with the help of calreticulin (Hsu et al, 1991;Paulsson et al, 2006;Garstka et al, 2007;Purcell and Elliott, 2008;Wearsch and Cresswell, 2008;Howe et al, 2009;Zhang et al, 2011). This second system is responsible for the intracellular retention of tapasin-dependent MHC-I allotypes in tapasin-deficient cells (Peh et al, 1998;Garstka et al, 2011).…”